Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03584152 · ClinicalTrials.gov registry record · Phase 2
Postoperative Pain Management in Rhinoplasty
A Phase 2 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 159
- Enrollment target
NCT03584152: Completed Phase 2 study, sponsored by Stanford University.
NCT03584152 is a Phase 2 study that has completed, run by Stanford University. The registered enrollment target is 159 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03584152, a Phase 2 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 159 participants
- Enrollment target
Study Summary
The primary purpose of the study is to determine adequacy of postoperative pain control after nasal surgery in patients prescribed Acetaminophen (325mg) + Hydrocodone (5mg) compared to Acetaminophen(325mg) + Ibuprofen (200mg)for a period of 5 days after nasal surgery. To assess the degree of pain, the participants will score the intensity of their pain on a visual analog scale(VAS)of 0-100points (0- no pain and 100- most severe pain), preoperatively and postoperatively (to be documented before each dose) for the duration of the prescribed medications . Additionally, the study will also seek to track: 1. The total number of pills each patients consume from the prescribed 5 day regimen. 2. Any associated side effects. 3. Additional pain medications prescribed in case of inadequate pain control, postoperatively.
Interventions
- DRUG Norco 5Mg-325Mg Tablet
- DRUG Ibuprofen 200 mg
- DRUG Tylenol 325Mg Caplet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2019-08-09 |
| Est. Completion | 2025-07-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03584152
The ClinicalTrials.gov registry entry for NCT03584152 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Norco 5Mg-325Mg Tablet is the first listed.
NCT03584152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03584152 about?
NCT03584152 is a clinical study titled "Postoperative Pain Management in Rhinoplasty". The primary purpose of the study is to determine adequacy of postoperative pain control after nasal surgery in patients prescribed Acetaminophen (325mg) + Hydrocodone (5mg) compared to Acetaminophen(325mg) + Ibuprofen (200mg)for a period of 5 days after nasal surgery. To assess the degree of pain, t...
What is the current status of trial NCT03584152?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 159 participants. The study started on 2019-08-09. Estimated completion is 2025-07-17.
What interventions are being tested in trial NCT03584152?
The interventions under investigation include: Norco 5Mg-325Mg Tablet (DRUG), Ibuprofen 200 mg (DRUG), Tylenol 325Mg Caplet (DRUG).
Who is sponsoring clinical trial NCT03584152?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.